Patients with type 1 or type 2 diabetes who experience nausea, vomiting, or malaise or develop a metabolic acidosis in the setting of SGLT-2 inhibitor therapy should be promptly evaluated for the ...
What Causes Diabetic Ketoacidosis? — People can get diabetic ketoacidosis for a few reasons: ¡ They are not getting treated for diabetes (possibly because they don’t know they have it) and so their ...
Metformin is a safe, well-tolerated agent that inhibits gluconeogenesis; however, it carries a small risk of inducing lactic acidosis and ... (344 in 2005), diabetes is second only to cancer ...
Oct. 31, 2024 — Children who experienced sugar restrictions during their first 1,000 days after conception had up to 35% lower risk of developing type 2 diabetes and as much as 20% less risk of ...
The following six News and Views articles discuss how The Human Genome Project will revolutionize the diagnosis and treatment of diseases including diabetes, asthma, cancer, autoimmunity and ...
From 2010 to 2023, GLP-1RAs and SGLT2 inhibitors saw rising prescriptions in type 1 diabetes, particularly for patients with obesity and cardiorenal risks. The study reveals that long-term fasting ...
Diabetic ketoacidosis, or DKA, is a life-threatening condition that develops when the body is unable to break down blood sugar appropriately and begins breaking down large amounts of fat instead ...
Diabetes is a medical condition that affects blood sugar levels. Normally, people’s bodies maintain the ideal blood sugar levels automatically. When a person has diabetes, their body fails to maintain ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...